Neurogene Inc. (NGNE) Operating cash flow 2016–2025
Neurogene Inc. (NGNE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$77.2MFY2025 · since FY2016: -$30.2M → -$77.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$77.2M | -9.3% |
| FY2024 | -$70.6M | -37.3% |
| FY2023 | -$51.4M | +2.7% |
| FY2022 | -$52.8M | -11.1% |
| FY2021 | -$47.6M | -93.5% |
| FY2020 | -$24.6M | -59.6% |
| FY2019 | -$15.4M | +51.2% |
| FY2018 | -$31.6M | +29.4% |
| FY2017 | -$44.7M | -47.9% |
| FY2016 | -$30.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NGNE financial trends
NGNE RevenueNGNE Net incomeNGNE Net marginNGNE Gross profitNGNE Gross marginNGNE Operating incomeNGNE Operating marginNGNE Free cash flowNGNE Capital expendituresNGNE Return on equityNGNE Stock buybacksNGNE Dividends paidNGNE Total assetsNGNE Total liabilitiesNGNE Shareholders’ equityNGNE overview →